US 9956215
Methods of treating cancer with farnesyltransferase inhibitors
granted A61KA61K31/4709A61K45/06
Quick answer
US patent 9956215 (Methods of treating cancer with farnesyltransferase inhibitors) held by Kura Oncology, Inc. expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4709, A61K45/06